论文部分内容阅读
目的:分析小儿哮喘急性发作采用孟鲁司特钠联合6-542治疗的临床效果。方法:收治婴幼儿哮喘急性发作患儿81例,随机分成两组,对照给予常规综合治疗,治疗组在此基础上给予口服孟鲁司特治疗,并给予静脉滴注6-542,评价临床效果。结果:治疗组总有效率97.6%,高于对照组的87.2%,组间差异有统计学意义(P<0.05);两组均未发现明显不良反应。结论:小儿哮喘急性发作采用孟鲁司特钠联合6-542治疗疗效肯定,不良反应少,可用于临床治疗。
Objective: To analyze the clinical effect of montelukast combined with 6-542 in the treatment of acute asthma attack in children. Methods: Eighty-one infants with acute asthma attack were randomly divided into two groups. The control group was given conventional comprehensive treatment. The treatment group was given montelukast on the basis of the above treatment. The patients were given 6-542 intravenous drip to evaluate the clinical effect . Results: The total effective rate of the treatment group was 97.6%, which was higher than that of the control group (87.2%). The difference between the two groups was statistically significant (P <0.05). No obvious adverse reactions were found in both groups. Conclusion: The treatment of acute asthma in children with montelukate combined with 6-542 is effective and has few side effects. It can be used in clinical treatment.